首页 > 最新文献

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie最新文献

英文 中文
Advancing the visibility of outer retinal integrity in neovascular age-related macular degeneration with high-resolution OCT 利用高分辨率 OCT 提高新生血管性老年黄斑变性患者视网膜外层完整性的可见度。
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.05.014
Veronika Prenner , Gregor Sebastian Reiter , Philipp Fuchs , Klaudia Birner , Sophie Frank , Leonard Coulibaly , Markus Gumpinger , Hrvoje Bogunovic , Ursula Schmidt-Erfurth
<div><h3>Objective</h3><div>To compare the visibility and accessibility of the outer retina in neovascular age-related macular degeneration (nAMD) between 2 OCT devices.</div></div><div><h3>Methods</h3><div>In this prospective, cross-sectional exploratory study, differences in thickness and loss of individual outer retinal layers in eyes with nAMD and in age-matched healthy eyes between a next-level High-Res OCT device and the conventional SPECTRALIS OCT (both Heidelberg Engineering GmbH, Heidelberg, Germany) were analyzed. Eyes with nAMD and at least 250 nL of retinal fluid, quantified by an approved deep-learning algorithm (Fluid Monitor, RetInSight, Vienna, Austria), fulfilled the inclusion criteria. The outer retinal layers were segmented using automated layer segmentation and were corrected manually. Layer loss and thickness were compared between both devices using a linear mixed-effects model and a paired <em>t</em> test.</div></div><div><h3>Results</h3><div>Nineteen eyes of 17 patients with active nAMD and 17 healthy eyes were included. For nAMD eyes, the thickness of the retinal pigment epithelium (RPE) differed significantly between the devices (25.42 μm [95% CI, 14.24–36.61] and 27.31 μm [95% CI, 16.12–38.50] for high-resolution OCT and conventional OCT, respectively; <em>p</em> = 0.033). Furthermore, a significant difference was found in the mean relative external limiting membrane loss (<em>p</em> = 0.021). However, the thickness of photoreceptors, RPE integrity loss, and photoreceptor integrity loss did not differ significantly between devices in the central 3 mm. In healthy eyes, a significant difference in both RPE and photoreceptor thickness between devices was shown (<em>p</em> < 0.001).</div></div><div><h3>Conclusion</h3><div>Central RPE thickness was significantly thinner on high-resolution OCT compared with conventional OCT images explained by superior optical separation of the RPE and Bruch's membrane.</div></div><div><h3>Objectif</h3><div>Comparer la visibilité et l'accessibilité de la rétine externe dans la dégénérescence maculaire liée à l’âge néovasculaire (DMLAn) mesurées par deux appareils de tomographie par cohérence optique (OCT).</div></div><div><h3>Méthodes</h3><div>Dans le cadre de notre étude exploratoire transversale prospective, les différences quant à l’épaisseur et à la perte des couches rétiniennes externes individuelles dans des yeux atteints de DMLAn et dans des yeux sains appariés pour l’âge ont été mesurées par deux appareils d'OCT (Heidelberg Engineering GmbH, Heidelberg, Allemagne), soit un tomographe en haute résolution dernier cri, et le tomographe SPECTRALIS® classique. Les yeux atteints d'une DMLAn et présentant au moins 250 nL de liquide rétinien, quantifié par un algorithme d'apprentissage profond approuvé (dispositif de surveillance de liquide, RetInSight, Vienne, Autriche), répondaient aux critères d'inclusion. On a procédé à une segmentation automatique des couches rétiniennes externes que l
目的比较两种 OCT 设备在新生血管性老年黄斑变性(nAMD)患者视网膜外层的可见性和可及性:在这项前瞻性、横断面探索性研究中,我们分析了下一代高分辨率 OCT 设备和传统 SPECTRALIS OCT(均为德国海德堡海德堡工程有限公司生产)在新生血管性老年性黄斑变性患者和年龄匹配的健康眼中视网膜外层厚度和各层损失的差异。经认可的深度学习算法(Fluid Monitor, RetInSight, Vienna, Austria)量化的 nAMD 眼球和至少 250 nL 的视网膜积液符合纳入标准。视网膜外层采用自动视网膜层分割法进行分割,并进行人工校正。使用线性混合效应模型和配对 t 检验比较两种设备的视网膜层损失和厚度:共纳入了 17 名活动性 nAMD 患者和 17 名健康患者的 19 只眼睛。对于 nAMD 眼睛,两种设备的视网膜色素上皮(RPE)厚度差异显著(高分辨率 OCT 和传统 OCT 分别为 25.42 μm [95% CI,14.24-36.61] 和 27.31 μm [95% CI,16.12-38.50];P = 0.033)。此外,平均相对外缘膜损耗也存在明显差异(p = 0.021)。然而,在中央 3 毫米的范围内,不同设备的感光体厚度、RPE 完整性损失和感光体完整性损失没有显著差异。在健康眼睛中,不同设备的 RPE 和光感受器厚度均有显著差异(p < 0.001):结论:与传统 OCT 图像相比,高分辨率 OCT 图像的中央 RPE 厚度明显较薄,这是因为 RPE 和布鲁氏膜的光学分离度较高。
{"title":"Advancing the visibility of outer retinal integrity in neovascular age-related macular degeneration with high-resolution OCT","authors":"Veronika Prenner ,&nbsp;Gregor Sebastian Reiter ,&nbsp;Philipp Fuchs ,&nbsp;Klaudia Birner ,&nbsp;Sophie Frank ,&nbsp;Leonard Coulibaly ,&nbsp;Markus Gumpinger ,&nbsp;Hrvoje Bogunovic ,&nbsp;Ursula Schmidt-Erfurth","doi":"10.1016/j.jcjo.2024.05.014","DOIUrl":"10.1016/j.jcjo.2024.05.014","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To compare the visibility and accessibility of the outer retina in neovascular age-related macular degeneration (nAMD) between 2 OCT devices.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;In this prospective, cross-sectional exploratory study, differences in thickness and loss of individual outer retinal layers in eyes with nAMD and in age-matched healthy eyes between a next-level High-Res OCT device and the conventional SPECTRALIS OCT (both Heidelberg Engineering GmbH, Heidelberg, Germany) were analyzed. Eyes with nAMD and at least 250 nL of retinal fluid, quantified by an approved deep-learning algorithm (Fluid Monitor, RetInSight, Vienna, Austria), fulfilled the inclusion criteria. The outer retinal layers were segmented using automated layer segmentation and were corrected manually. Layer loss and thickness were compared between both devices using a linear mixed-effects model and a paired &lt;em&gt;t&lt;/em&gt; test.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Nineteen eyes of 17 patients with active nAMD and 17 healthy eyes were included. For nAMD eyes, the thickness of the retinal pigment epithelium (RPE) differed significantly between the devices (25.42 μm [95% CI, 14.24–36.61] and 27.31 μm [95% CI, 16.12–38.50] for high-resolution OCT and conventional OCT, respectively; &lt;em&gt;p&lt;/em&gt; = 0.033). Furthermore, a significant difference was found in the mean relative external limiting membrane loss (&lt;em&gt;p&lt;/em&gt; = 0.021). However, the thickness of photoreceptors, RPE integrity loss, and photoreceptor integrity loss did not differ significantly between devices in the central 3 mm. In healthy eyes, a significant difference in both RPE and photoreceptor thickness between devices was shown (&lt;em&gt;p&lt;/em&gt; &lt; 0.001).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Central RPE thickness was significantly thinner on high-resolution OCT compared with conventional OCT images explained by superior optical separation of the RPE and Bruch's membrane.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Comparer la visibilité et l'accessibilité de la rétine externe dans la dégénérescence maculaire liée à l’âge néovasculaire (DMLAn) mesurées par deux appareils de tomographie par cohérence optique (OCT).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Dans le cadre de notre étude exploratoire transversale prospective, les différences quant à l’épaisseur et à la perte des couches rétiniennes externes individuelles dans des yeux atteints de DMLAn et dans des yeux sains appariés pour l’âge ont été mesurées par deux appareils d'OCT (Heidelberg Engineering GmbH, Heidelberg, Allemagne), soit un tomographe en haute résolution dernier cri, et le tomographe SPECTRALIS® classique. Les yeux atteints d'une DMLAn et présentant au moins 250 nL de liquide rétinien, quantifié par un algorithme d'apprentissage profond approuvé (dispositif de surveillance de liquide, RetInSight, Vienne, Autriche), répondaient aux critères d'inclusion. On a procédé à une segmentation automatique des couches rétiniennes externes que l","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages 42-49"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141431527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a slit lamp program on medical student competence, confidence, and career interests 裂隙灯项目对医学生能力、信心和职业兴趣的影响。
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.08.015
Natalie Mezey , Wilma Hopman , Rachel Curtis
{"title":"Impact of a slit lamp program on medical student competence, confidence, and career interests","authors":"Natalie Mezey ,&nbsp;Wilma Hopman ,&nbsp;Rachel Curtis","doi":"10.1016/j.jcjo.2024.08.015","DOIUrl":"10.1016/j.jcjo.2024.08.015","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages e149-e151"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142280673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual impairment, employment status, and reduction in income: the Canadian Longitudinal Study on Aging 视力障碍、就业状况和收入减少:加拿大老龄问题纵向研究
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.04.006
Emma Iverson , Mahadeo Sukhai , Matthew P. Quinn , Marie-Josée Aubin , Ellen E. Freeman
<div><h3>Objective</h3><div>To examine the employment status of those with and without visual impairment and eye disease and to examine the association between visual impairment and eye disease and a reduction in income over a 3-year period.</div></div><div><h3>Design</h3><div>Population-based prospective cohort study.</div></div><div><h3>Participants</h3><div>A total of 12,174 nonretired participants aged 45–64 years old in the Canadian Longitudinal Study on Aging.</div></div><div><h3>Methods</h3><div>Visual impairment was defined if binocular presenting or pinhole-corrected monocular visual acuity in the better eye was worse than 20/40 at baseline. Self-reported diagnoses of age-related macular degeneration (AMD) and glaucoma were collected. Employment status (employed, not employed due to sickness or disability, or unemployed) was based on questions on labour force participation. Income reduction was defined as household income <$50,000 per year at follow-up when household income was ≥$50,000 at baseline. Multinomial and logistic regressions were used to adjust for demographic and health variables.</div></div><div><h3>Results</h3><div>Visual impairment using binocular presenting visual acuity (odds ratio [OR] = 2.09; 95% CI, 1.21–3.62) and pinhole-corrected visual acuity (OR = 2.99; 95% CI, 1.54–5.83) were associated with a higher odds of not being employed due to sickness or disability after adjustment. AMD (OR = 1.82; 95% CI, 1.11–3.01) and glaucoma (OR = 2.05; 95% CI, 1.28–3.28) at baseline were both associated with reductions in income over a 3-year period after adjustment.</div></div><div><h3>Conclusion</h3><div>Individuals with visual impairment experienced lower employment, and those with AMD or glaucoma were more likely to have their incomes decline over 3 years. Policies to improve workplace participation by those with vision loss are needed.</div></div><div><h3>Objectif</h3><div>Examiner la situation de l'emploi en fonction de la déficience visuelle et des pathologies oculaires et analyser le lien entre la présence d'une déficience visuelle et d'une pathologie oculaire, d'une part, et une baisse des revenus sur une période de 3 ans, d'autre part.</div></div><div><h3>Nature</h3><div>Étude de cohorte populationnelle prospective.</div></div><div><h3>Participants</h3><div>Un total de 12 174 participants à l’Étude longitudinale canadienne sur le vieillissement âgés de 45 à 64 ans qui n’étaient pas à la retraite.</div></div><div><h3>Méthodes</h3><div>La déficience visuelle se définissait comme suit : acuité visuelle binoculaire au moment de l'examen ou acuité visuelle monoculaire corrigée au trou sténopéique du meilleur œil inférieure à 20/40 au départ. On a également consigné les diagnostics spontanément signalés de dégénérescence maculaire liée à l’âge (DMLA) et de glaucome. La situation de l'emploi (avec emploi, sans emploi en raison d'une maladie ou d'un handicap ou sans emploi) a été déterminée à partir de questions sur la présence
{"title":"Visual impairment, employment status, and reduction in income: the Canadian Longitudinal Study on Aging","authors":"Emma Iverson ,&nbsp;Mahadeo Sukhai ,&nbsp;Matthew P. Quinn ,&nbsp;Marie-Josée Aubin ,&nbsp;Ellen E. Freeman","doi":"10.1016/j.jcjo.2024.04.006","DOIUrl":"10.1016/j.jcjo.2024.04.006","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To examine the employment status of those with and without visual impairment and eye disease and to examine the association between visual impairment and eye disease and a reduction in income over a 3-year period.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Design&lt;/h3&gt;&lt;div&gt;Population-based prospective cohort study.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Participants&lt;/h3&gt;&lt;div&gt;A total of 12,174 nonretired participants aged 45–64 years old in the Canadian Longitudinal Study on Aging.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Visual impairment was defined if binocular presenting or pinhole-corrected monocular visual acuity in the better eye was worse than 20/40 at baseline. Self-reported diagnoses of age-related macular degeneration (AMD) and glaucoma were collected. Employment status (employed, not employed due to sickness or disability, or unemployed) was based on questions on labour force participation. Income reduction was defined as household income &lt;$50,000 per year at follow-up when household income was ≥$50,000 at baseline. Multinomial and logistic regressions were used to adjust for demographic and health variables.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Visual impairment using binocular presenting visual acuity (odds ratio [OR] = 2.09; 95% CI, 1.21–3.62) and pinhole-corrected visual acuity (OR = 2.99; 95% CI, 1.54–5.83) were associated with a higher odds of not being employed due to sickness or disability after adjustment. AMD (OR = 1.82; 95% CI, 1.11–3.01) and glaucoma (OR = 2.05; 95% CI, 1.28–3.28) at baseline were both associated with reductions in income over a 3-year period after adjustment.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;Individuals with visual impairment experienced lower employment, and those with AMD or glaucoma were more likely to have their incomes decline over 3 years. Policies to improve workplace participation by those with vision loss are needed.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Examiner la situation de l'emploi en fonction de la déficience visuelle et des pathologies oculaires et analyser le lien entre la présence d'une déficience visuelle et d'une pathologie oculaire, d'une part, et une baisse des revenus sur une période de 3 ans, d'autre part.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Nature&lt;/h3&gt;&lt;div&gt;Étude de cohorte populationnelle prospective.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Participants&lt;/h3&gt;&lt;div&gt;Un total de 12 174 participants à l’Étude longitudinale canadienne sur le vieillissement âgés de 45 à 64 ans qui n’étaient pas à la retraite.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;La déficience visuelle se définissait comme suit : acuité visuelle binoculaire au moment de l'examen ou acuité visuelle monoculaire corrigée au trou sténopéique du meilleur œil inférieure à 20/40 au départ. On a également consigné les diagnostics spontanément signalés de dégénérescence maculaire liée à l’âge (DMLA) et de glaucome. La situation de l'emploi (avec emploi, sans emploi en raison d'une maladie ou d'un handicap ou sans emploi) a été déterminée à partir de questions sur la présence","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages e16-e22"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141135540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anaplastic lymphoma kinase-positive histiocytosis with periorbital involvement: a novel presentation 眶周受累的无细胞淋巴瘤激酶阳性组织细胞增生症:一种新的表现形式。
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.06.013
Meng-Ju Lin , Kuan-Ting Kuo , Shu-Lang Liao , Yi-Hsuan Wei
{"title":"Anaplastic lymphoma kinase-positive histiocytosis with periorbital involvement: a novel presentation","authors":"Meng-Ju Lin ,&nbsp;Kuan-Ting Kuo ,&nbsp;Shu-Lang Liao ,&nbsp;Yi-Hsuan Wei","doi":"10.1016/j.jcjo.2024.06.013","DOIUrl":"10.1016/j.jcjo.2024.06.013","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages e165-e167"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orbital decompression following treatment with teprotumumab for thyroid eye disease 使用替普鲁单抗治疗甲状腺眼病后的眼眶减压。
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.06.003
Nicole J. Topilow , Rafaella Cleto Penteado , Michelle Ting , Eman Al-Sharif , George A. Villatoro , Jin Sook Yoon , Catherine Y. Liu , Bobby S. Korn , Don O. Kikkawa
<div><h3>Objective</h3><div>To quantify the observed decrease in orbital decompressions being performed at one tertiary care institution and to determine the rate and predictive factors of orbital decompression surgery following treatment with teprotumumab for thyroid eye disease.</div></div><div><h3>Methods</h3><div>Epic's SlicerDicer program was used to analyze recent trends in the overall number of thyroid eye disease (TED) patients evaluated in the oculoplastic surgery department, as well as usage trends of CPT codes 67445 (lateral orbitotomy with bone removal for decompression) and 67414 (orbitotomy with removal of bone for decompression). A retrospective chart review of active moderate-to-severe TED patients treated with teprotumumab was performed at a single tertiary care center. The main outcome measure was whether or not patients underwent bony orbital decompression surgery following treatment with teprotumumab. The SlicerDicer search demonstrated stable usage of CPT codes 67445 and 67414 from 2016 to 2019, followed by a significant decrease from 2020 to 2023, over a background of increasing numbers of TED patients evaluated in clinic. Following teprotumumab therapy, 25% of patients and 18% of orbits underwent bony decompression. Surgically decompressed patients had higher pre- and post-teprotumumab exophthalmometry measurements compared with patients who did not undergo bony decompression. Average time to decompression following conclusion or cessation of teprotumumab therapy was 12.6 months.</div></div><div><h3>Conclusion</h3><div>While the number of TED patients treated at one tertiary care center has risen over recent years, the number of orbital decompression surgeries has declined. Orbital decompression, however, is still needed in select patients after treatment with teprotumumab.</div></div><div><h3>Objectif</h3><div>Quantifier la baisse observée du nombre de décompressions orbitaires réalisées dans un établissement de soins tertiaires, calculer le taux de ce type de chirurgie après l'administration de téprotumumab dans le traitement de l'ophtalmopathie thyroïdienne (OT) et faire ressortir les facteurs de prédiction à cet égard.</div></div><div><h3>Méthodes</h3><div>Le programme SlicerDicer d'Epic a servi à analyser les tendances récentes quant au nombre global de patients présentant une OT qui ont été évalués au service de chirurgie oculoplastique de même que les tendances en matière d'utilisation des codes d'identification 67445 (orbitotomie latérale comprenant une résection osseuse afin de réaliser une décompression) et 67414 (orbitotomie comprenant une résection osseuse afin de réaliser une décompression) selon la <em>Current Procedural Terminology</em> (CPT). Un examen rétrospectif des dossiers médicaux de patients présentant une OT évolutive modérée à grave et qui ont reçu le téprotumumab a eu lieu dans un établissement de soins tertiaires unique. Le principal paramètre de mesure reposait sur la réalisation – ou non – d'une
目的量化一家三级医疗机构眼眶减压手术的减少情况,并确定甲状腺眼病患者接受替普鲁单抗治疗后眼眶减压手术的比例和预测因素:方法:使用Epic的SlicerDicer程序分析眼部整形外科评估的甲状腺眼病(TED)患者总人数的最新趋势,以及CPT代码67445(为减压而进行外侧眶骨切除术)和67414(为减压而进行眶骨切除术)的使用趋势。一家三级医疗中心对接受过替普鲁单抗治疗的活动性中度至重度 TED 患者进行了回顾性病历审查。主要结果指标是患者在接受替普鲁单抗治疗后是否接受了骨性眼眶减压手术。SlicerDicer搜索显示,在临床评估的TED患者人数不断增加的背景下,CPT代码67445和67414的使用率在2016年至2019年期间保持稳定,随后在2020年至2023年期间显著下降。泰泊单抗治疗后,25%的患者和18%的眼眶接受了骨减压。与未接受骨减压的患者相比,接受手术减压的患者在接受替普鲁单抗治疗前后的眼球外径测量值更高。泰泊单抗治疗结束或停止后的平均减压时间为12.6个月:结论:近年来,在一家三级医疗中心接受治疗的 TED 患者人数有所增加,但眼眶减压手术的数量却有所下降。结论:近年来,虽然一家三级医疗中心治疗的 TED 患者人数有所增加,但眼眶减压手术的数量却有所下降。然而,在使用替普鲁单抗治疗后,仍有部分患者需要进行眼眶减压手术。
{"title":"Orbital decompression following treatment with teprotumumab for thyroid eye disease","authors":"Nicole J. Topilow ,&nbsp;Rafaella Cleto Penteado ,&nbsp;Michelle Ting ,&nbsp;Eman Al-Sharif ,&nbsp;George A. Villatoro ,&nbsp;Jin Sook Yoon ,&nbsp;Catherine Y. Liu ,&nbsp;Bobby S. Korn ,&nbsp;Don O. Kikkawa","doi":"10.1016/j.jcjo.2024.06.003","DOIUrl":"10.1016/j.jcjo.2024.06.003","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To quantify the observed decrease in orbital decompressions being performed at one tertiary care institution and to determine the rate and predictive factors of orbital decompression surgery following treatment with teprotumumab for thyroid eye disease.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Epic's SlicerDicer program was used to analyze recent trends in the overall number of thyroid eye disease (TED) patients evaluated in the oculoplastic surgery department, as well as usage trends of CPT codes 67445 (lateral orbitotomy with bone removal for decompression) and 67414 (orbitotomy with removal of bone for decompression). A retrospective chart review of active moderate-to-severe TED patients treated with teprotumumab was performed at a single tertiary care center. The main outcome measure was whether or not patients underwent bony orbital decompression surgery following treatment with teprotumumab. The SlicerDicer search demonstrated stable usage of CPT codes 67445 and 67414 from 2016 to 2019, followed by a significant decrease from 2020 to 2023, over a background of increasing numbers of TED patients evaluated in clinic. Following teprotumumab therapy, 25% of patients and 18% of orbits underwent bony decompression. Surgically decompressed patients had higher pre- and post-teprotumumab exophthalmometry measurements compared with patients who did not undergo bony decompression. Average time to decompression following conclusion or cessation of teprotumumab therapy was 12.6 months.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;While the number of TED patients treated at one tertiary care center has risen over recent years, the number of orbital decompression surgeries has declined. Orbital decompression, however, is still needed in select patients after treatment with teprotumumab.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objectif&lt;/h3&gt;&lt;div&gt;Quantifier la baisse observée du nombre de décompressions orbitaires réalisées dans un établissement de soins tertiaires, calculer le taux de ce type de chirurgie après l'administration de téprotumumab dans le traitement de l'ophtalmopathie thyroïdienne (OT) et faire ressortir les facteurs de prédiction à cet égard.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Méthodes&lt;/h3&gt;&lt;div&gt;Le programme SlicerDicer d'Epic a servi à analyser les tendances récentes quant au nombre global de patients présentant une OT qui ont été évalués au service de chirurgie oculoplastique de même que les tendances en matière d'utilisation des codes d'identification 67445 (orbitotomie latérale comprenant une résection osseuse afin de réaliser une décompression) et 67414 (orbitotomie comprenant une résection osseuse afin de réaliser une décompression) selon la &lt;em&gt;Current Procedural Terminology&lt;/em&gt; (CPT). Un examen rétrospectif des dossiers médicaux de patients présentant une OT évolutive modérée à grave et qui ont reçu le téprotumumab a eu lieu dans un établissement de soins tertiaires unique. Le principal paramètre de mesure reposait sur la réalisation – ou non – d'une","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages e59-e64"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141765542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resident Perspectives 60–1
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jcjo.2024.12.004
{"title":"Resident Perspectives 60–1","authors":"","doi":"10.1016/j.jcjo.2024.12.004","DOIUrl":"10.1016/j.jcjo.2024.12.004","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":"60 1","pages":"Pages e154-e159"},"PeriodicalIF":3.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143131730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomic and visual outcomes of pars plana vitrectomy in patients with incomplete closure of Zone 3 scleral lacerations.
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-31 DOI: 10.1016/j.jcjo.2025.01.010
Sami H Uwaydat, Muhammad Z Chauhan, Pedro S Tetelbom
{"title":"Anatomic and visual outcomes of pars plana vitrectomy in patients with incomplete closure of Zone 3 scleral lacerations.","authors":"Sami H Uwaydat, Muhammad Z Chauhan, Pedro S Tetelbom","doi":"10.1016/j.jcjo.2025.01.010","DOIUrl":"10.1016/j.jcjo.2025.01.010","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement of stereopsis following strabismus surgery in adults: a retrospective analysis. 成人斜视手术后立体视功能的改善:回顾性分析。
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-31 DOI: 10.1016/j.jcjo.2024.12.007
Oded Rock, Tiran Golani, Sari David, Mor Vered, Rasha Mosleh, Sharon Armarnik, Tamara Wygnanski-Jaffe

Objective: Adults who undergo strabismus surgery, in addition to cosmesis, could benefit from improved stereopsis. This improvement is associated with the performance of motor skill tasks in young adults; they reduce the risk of tripping or falling during everyday locomotion and improve reading efficiency. This study aimed to assess stereopsis level after strabismus surgery in adults who underwent strabismus surgery for any reason.

Methods: Retrospective observational study of adult patients who underwent strabismus surgery at our institution between 2010 and 2022.

Results: One hundred and thirty-two patients were included. Postoperatively, 48% had a stereo acuity better than 100 seconds of arc, and only 21.5% had no stereopsis. The most significant factor influencing improved stereopsis after surgery was the angle of strabismus postoperatively (p = 0.018). There was a statistically significant correlation between fusion at a distance and the stereo acuity (p = 0.0337). There was no statistically significant correlation between the stereo acuity level and the strabismus angle of deviation, the strabismus direction (vertical, horizontal, or combined), or the type (esotropia or exotropia) before or after the surgery. Although not statistically significant (p = 0.6579), the underlying cause categories were correlated with the stereo level. Patients with neurological causes demonstrated higher levels of stereopsis, followed by TED, whereas patients with childhood strabismus have the lowest probability of regaining stereopsis after surgery.

Conclusions: Although long-standing strabismus reduces the potential for binocularity, surgery may be beneficial and improve stereopsis regardless of the cause of strabismus.

目的:成人斜视手术,除了美容,可以受益于立体视觉的改善。这种改善与年轻人运动技能任务的表现有关;它们减少了在日常运动中绊倒或跌倒的风险,提高了阅读效率。本研究旨在评估因任何原因接受斜视手术的成人斜视手术后的立体视水平。方法:对2010年至2022年在我院接受斜视手术的成人患者进行回顾性观察研究。结果:纳入132例患者。术后,48%的人立体视力优于100秒弧度,只有21.5%的人没有立体视觉。影响术后立体视觉改善的最显著因素是术后斜视角度(p = 0.018)。远处融合与立体视敏度有统计学意义(p = 0.0337)。手术前后立体视敏度水平与斜视偏斜角、斜视方向(垂直、水平或联合)、斜视类型(内斜视或外斜视)均无统计学意义。虽然没有统计学意义(p = 0.6579),但潜在原因类别与立体立体水平相关。神经系统疾病患者的立体视觉水平较高,其次是TED,而儿童斜视患者在手术后恢复立体视觉的可能性最低。结论:尽管长期斜视降低了双眼视的可能性,但手术可能是有益的,可以改善立体视,而不考虑斜视的原因。
{"title":"Improvement of stereopsis following strabismus surgery in adults: a retrospective analysis.","authors":"Oded Rock, Tiran Golani, Sari David, Mor Vered, Rasha Mosleh, Sharon Armarnik, Tamara Wygnanski-Jaffe","doi":"10.1016/j.jcjo.2024.12.007","DOIUrl":"10.1016/j.jcjo.2024.12.007","url":null,"abstract":"<p><strong>Objective: </strong>Adults who undergo strabismus surgery, in addition to cosmesis, could benefit from improved stereopsis. This improvement is associated with the performance of motor skill tasks in young adults; they reduce the risk of tripping or falling during everyday locomotion and improve reading efficiency. This study aimed to assess stereopsis level after strabismus surgery in adults who underwent strabismus surgery for any reason.</p><p><strong>Methods: </strong>Retrospective observational study of adult patients who underwent strabismus surgery at our institution between 2010 and 2022.</p><p><strong>Results: </strong>One hundred and thirty-two patients were included. Postoperatively, 48% had a stereo acuity better than 100 seconds of arc, and only 21.5% had no stereopsis. The most significant factor influencing improved stereopsis after surgery was the angle of strabismus postoperatively (p = 0.018). There was a statistically significant correlation between fusion at a distance and the stereo acuity (p = 0.0337). There was no statistically significant correlation between the stereo acuity level and the strabismus angle of deviation, the strabismus direction (vertical, horizontal, or combined), or the type (esotropia or exotropia) before or after the surgery. Although not statistically significant (p = 0.6579), the underlying cause categories were correlated with the stereo level. Patients with neurological causes demonstrated higher levels of stereopsis, followed by TED, whereas patients with childhood strabismus have the lowest probability of regaining stereopsis after surgery.</p><p><strong>Conclusions: </strong>Although long-standing strabismus reduces the potential for binocularity, surgery may be beneficial and improve stereopsis regardless of the cause of strabismus.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143000604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological comparison of benign eyelid tumours in tertiary care centers in Lima and Montreal from 2010 to 2019.
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-31 DOI: 10.1016/j.jcjo.2025.01.008
Katherine Jara, Emma Youhnovska, Emily Marcotte, Leila Marroquín, Jorge Villalobos, Yuliana Alvarez, Asami Kawaguchi, Erick Urbano, Jose Velasco-Stoll, Pedro Muro, Christian El-Hadad, Bryan Arthurs, Miguel N Burnier

Objective: The eyelids are complex structures composed of various tissues. As such, a wide array of lesions exist that affect the eyelids. Clinical diagnosis of these lesions is essential to differentiate benign from malignant ones. Although accurate, some cases are misdiagnosed. Histopathology remains the crucial step in the final diagnosis of eyelid lesions. The objective of the study is to describe and compare the clinicopathological diagnosis of benign eyelid tumours between two tertiary care centers, one in South America and the other in North America, from 2010 to 2019.

Methods: We reviewed 1 935 tumours at the McGill University Health Centre (MUHC)-McGill University Ocular Pathology and Translational Research Laboratory and 1 256 tumours collected at "Dr. Jose Antonio Avendaño Valdez" Ocular Pathology at the Instituto Nacional de Oftalmologia Peru (INO) (2010-2019). Demographic information and clinical and histopathological diagnoses were collected in an anonymized fashion.

Results: The average age was 61.04 years at MUHC and 47.44 years at INO, benign tumours accounted for 78.11 % and 79.84%, respectively. The three most frequent benign tumour were squamous cell papilloma, nevus, and seborrheic keratosis at both sites. Lesions most commonly affected the upper and lower eyelid. 2.32% at the MUHC and 1.35% at the INO of cases were clinically misdiagnosed as benign tumours but confirmed malignant by histopathology.

Conclusion: The most common lesions were squamous cell papilloma, nevus, and seborrheic keratosis, although the most common diagnosis varied, likely due to environmental factors differing at each site. Histopathology is essential for the accurate diagnosis of eyelid tumours.

{"title":"Clinicopathological comparison of benign eyelid tumours in tertiary care centers in Lima and Montreal from 2010 to 2019.","authors":"Katherine Jara, Emma Youhnovska, Emily Marcotte, Leila Marroquín, Jorge Villalobos, Yuliana Alvarez, Asami Kawaguchi, Erick Urbano, Jose Velasco-Stoll, Pedro Muro, Christian El-Hadad, Bryan Arthurs, Miguel N Burnier","doi":"10.1016/j.jcjo.2025.01.008","DOIUrl":"https://doi.org/10.1016/j.jcjo.2025.01.008","url":null,"abstract":"<p><strong>Objective: </strong>The eyelids are complex structures composed of various tissues. As such, a wide array of lesions exist that affect the eyelids. Clinical diagnosis of these lesions is essential to differentiate benign from malignant ones. Although accurate, some cases are misdiagnosed. Histopathology remains the crucial step in the final diagnosis of eyelid lesions. The objective of the study is to describe and compare the clinicopathological diagnosis of benign eyelid tumours between two tertiary care centers, one in South America and the other in North America, from 2010 to 2019.</p><p><strong>Methods: </strong>We reviewed 1 935 tumours at the McGill University Health Centre (MUHC)-McGill University Ocular Pathology and Translational Research Laboratory and 1 256 tumours collected at \"Dr. Jose Antonio Avendaño Valdez\" Ocular Pathology at the Instituto Nacional de Oftalmologia Peru (INO) (2010-2019). Demographic information and clinical and histopathological diagnoses were collected in an anonymized fashion.</p><p><strong>Results: </strong>The average age was 61.04 years at MUHC and 47.44 years at INO, benign tumours accounted for 78.11 % and 79.84%, respectively. The three most frequent benign tumour were squamous cell papilloma, nevus, and seborrheic keratosis at both sites. Lesions most commonly affected the upper and lower eyelid. 2.32% at the MUHC and 1.35% at the INO of cases were clinically misdiagnosed as benign tumours but confirmed malignant by histopathology.</p><p><strong>Conclusion: </strong>The most common lesions were squamous cell papilloma, nevus, and seborrheic keratosis, although the most common diagnosis varied, likely due to environmental factors differing at each site. Histopathology is essential for the accurate diagnosis of eyelid tumours.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pterygium-like conjunctival nevus: a clinicopathological study.
IF 3.3 4区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-01-30 DOI: 10.1016/j.jcjo.2025.01.009
Satoru Kase, Kiriko Hirooka, Emi Takakuwa, Susumu Ishida
{"title":"Pterygium-like conjunctival nevus: a clinicopathological study.","authors":"Satoru Kase, Kiriko Hirooka, Emi Takakuwa, Susumu Ishida","doi":"10.1016/j.jcjo.2025.01.009","DOIUrl":"10.1016/j.jcjo.2025.01.009","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143051679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1